Skip to main
AHR

AHR Stock Forecast & Price Target

AHR Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 23%
Buy 69%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

American Healthcare REIT Inc. reported robust same-store net operating income (NOI) growth, with its Senior Housing Operating Portfolio (SHOP) expanding by 25.3% and Integrated Senior Health Campus (ISHC) by 21.7% year-over-year. The company has demonstrated the highest funds from operations (FFO) growth rate within the healthcare REIT sector, bolstered by a favorable cost of capital since late 2024, positioning AHR to pursue strategic investments more aggressively. Additionally, the anticipated compounded annual growth rates (CAGR) of 11.8% and 15.5% for Trilogy and SHOP, respectively, signal strong organic growth potential driven by improved operational efficiencies and external market conditions.

Bears say

American Healthcare REIT Inc. is facing significant challenges that contribute to a negative outlook on its stock due to potential tenant risks and economic headwinds affecting its operations. Despite a reduction in net debt to annualized EBITDA from 5.1x to 3.5x and an improved liquidity position of $997 million, which includes substantial unrestricted cash and credit facility access, concerns remain about the ability of its tenants to maintain operational performance amid changing regulatory conditions. Additionally, if the company fails to meet organic net operating income growth expectations, which could be hindered by acquisition risks and lower Medicaid rates, this performance shortfall could adversely impact overall stock performance.

AHR has been analyzed by 13 analysts, with a consensus rating of Buy. 23% of analysts recommend a Strong Buy, 69% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About American Healthcare REIT Inc (AHR) Forecast

Analysts have given AHR a Buy based on their latest research and market trends.

According to 13 analysts, AHR has a Buy consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $50.54, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $50.54, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

American Healthcare REIT Inc (AHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.